AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7530680 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery alone for OSCST
Number of subjects: 0
Study 7530680 — intervention group
Group type: EXPERIMENTAL
Intervention: Platinum-based combination chemotherapy for OSCST with poor differentiation
Number of subjects: 0
Study 2980866 — intervention group
Group type: EXPERIMENTAL
Intervention: naloxone (10 mg sc)
Number of subjects: 10
Study 2980866 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 224345 — intervention group
Group type: EXPERIMENTAL
Intervention: Arsenic exposure in copper‐smelting factory workers
Number of subjects: 0
Study 224345 — intervention group
Group type: COMPARATOR
Intervention: Subclinical neuropathy
Number of subjects: 0
Study 224345 — intervention group
Group type: COMPARATOR
Intervention: Clinical neuropathy
Number of subjects: 0
Study 31116140 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative gastrectomy
Number of subjects: 0
Study 27797402 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 85
Study 25875011 — intervention group
Group type: EXPERIMENTAL
Intervention: Visceral osteopathic treatment (3 times during the first week of life)
Number of subjects: 41
Study 25875011 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 41
Study 25875011 — intervention group
Group type: EXPERIMENTAL
Intervention: Visceral osteopathic treatment
Number of subjects: 41
Study 23813263 — intervention group
Group type: EXPERIMENTAL
Intervention: FL/milk
Number of subjects: 20
Study 23813263 — intervention group
Group type: EXPERIMENTAL
Intervention: FL/juice
Number of subjects: 20
Study 23813263 — intervention group
Group type: EXPERIMENTAL
Intervention: FL/water
Number of subjects: 20
Study 23813263 — intervention group
Group type: COMPARATOR
Intervention: FL
Number of subjects: 20
Study 21407247 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut-enriched meat
Number of subjects: 22
Study 21407247 — intervention group
Group type: COMPARATOR
Intervention: Low-fat meat (LM)
Number of subjects: 22
Study 19366151 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-iliac bone transplantation (group A)
Number of subjects: 72
Study 19366151 — intervention group
Group type: COMPARATOR
Intervention: MSCs transplantation derived from human umbilical cord (group B)
Number of subjects: 72
Study 17925087 — intervention group
Group type: COMPARATOR
Intervention: Visual Inspection with Acetic Acid (VIA)
Number of subjects: 56147
Study 17925087 — intervention group
Group type: COMPARATOR
Intervention: Visual Inspection with Lugol's Iodine (VILI)
Number of subjects: 56147
Study 17925087 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined test (VIA + VILI)
Number of subjects: 56147
Study 17925087 — intervention group
Group type: COMPARATOR
Intervention: Combined test vs VIA alone
Number of subjects: 56147
Study 17925087 — intervention group
Group type: COMPARATOR
Intervention: Combined test vs VILI alone
Number of subjects: 56147
Study 17925087 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined test
Number of subjects: 56147
Study 17925087 — intervention group
Group type: COMPARATOR
Intervention: VILI as single test
Number of subjects: 56147
Study 14534771 — intervention group
Group type: COMPARATOR
Intervention: Nicotine patches (Nicotrol) 5 mg/day during week 1, 10 mg/day during week 2 and week 3, 5 mg/day during week 4
Number of subjects: 11
Study 14534771 — intervention group
Group type: COMPARATOR
Intervention: Nicotine patches (Nicotrol)
Number of subjects: 11
Study 11368437 — intervention group
Group type: EXPERIMENTAL
Intervention: MEC (mitoxantrone, etoposide, and cytarabine) plus PSC 833
Number of subjects: 23
Study 9553686 — intervention group
Group type: EXPERIMENTAL
Intervention: Patch 7D (7-day estradiol transdermal patch)
Number of subjects: 18
Study 8139084 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrine
Number of subjects: 2446
Study 8139084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2446
Study 3048363 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised directed coughing
Number of subjects: 38
Study 3048363 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (postural drainage, vibration and/or percussion and coughing)
Number of subjects: 38
Study 30589600 — intervention group
Group type: COMPARATOR
Intervention: Triptorelin 3.75 mg plus letrozole 2.5 mg/day
Number of subjects: 51
Study 30589600 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix 240 mg (day 1 of cycle 1) then 80 mg (day 1 of cycles 2-6) plus letrozole 2.5 mg/day
Number of subjects: 51
Study 30589600 — intervention group
Group type: COMPARATOR
Intervention: Triptorelin plus letrozole
Number of subjects: 51
Study 28322071 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal with normal bolus insulin and an additional 30% insulin bolus administered 3-h post-meal (HFA)
Number of subjects: 10
Study 28322071 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat meal with normal bolus insulin
Number of subjects: 10
Study 28322071 — intervention group
Group type: COMPARATOR
Intervention: High-fat meal with normal bolus insulin
Number of subjects: 10
Study 28322071 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 10
Study 25585612 — intervention group
Group type: EXPERIMENTAL
Intervention: One anastomosis gastric bypass (OAGB)
Number of subjects: 1000
Study 25585612 — intervention group
Group type: COMPARATOR
Intervention: Control group (Roux-en-Y gastric bypass - RYGB)
Number of subjects: 1000
Study 23043683 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3) 2000 IU/day for 6 months
Number of subjects: 28
Study 23043683 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 28
Study 20825496 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil treatment
Number of subjects: 114
Study 18331283 — intervention group
Group type: EXPERIMENTAL
Intervention: H. perforatum extract (300 mg, hypericin 0.31% and hyperforin 3.0%) taken three times a day for 12 weeks
Number of subjects: 43
Study 18331283 — intervention group
Group type: COMPARATOR
Intervention: Placebo (indistinguishable capsules) taken three times a day for 12 weeks
Number of subjects: 43
Study 17244684 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral beclomethasone dipropionate (BDP) 8 mg/d for 50 days
Number of subjects: 129
Study 17244684 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 14693409 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone 400 mg daily for 12 weeks
Number of subjects: 34
Study 14693409 — intervention group
Group type: COMPARATOR
Intervention: Metformin 750 mg daily
Number of subjects: 34
Study 11699125 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A (immediate denudation, immediate injection)
Number of subjects: 141
Study 11699125 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B (delayed denudation, delayed injection)
Number of subjects: 141
Study 11699125 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol C (early denudation, delayed injection)
Number of subjects: 141
Study 11699125 — intervention group
Group type: EXPERIMENTAL
Intervention: Preincubation with intact cumulus
Number of subjects: 141
Study 11699125 — intervention group
Group type: COMPARATOR
Intervention: No preincubation (implied control)
Number of subjects: 141
Study 9460726 — intervention group
Group type: EXPERIMENTAL
Intervention: Word fluency task with random production criteria
Number of subjects: 0
Study 9460726 — intervention group
Group type: COMPARATOR
Intervention: Word fluency task
Number of subjects: 0
Study 7957521 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous colchicine 0.5 mg (healthy volunteers)
Number of subjects: 10
Study 7957521 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous colchicine 1 mg (elderly group)
Number of subjects: 10
Study 7957521 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous colchicine (both groups)
Number of subjects: 10
Study 7957521 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous colchicine (healthy volunteers)
Number of subjects: 10
Study 7957521 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous colchicine (elderly subjects)
Number of subjects: 10
Study 7957521 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous colchicine (healthy group)
Number of subjects: 10
Study 7957521 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous colchicine (elderly group)
Number of subjects: 10
Study 7957521 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral colchicine 1 mg (healthy volunteers)
Number of subjects: 10
Study 7957521 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral colchicine 1 mg (elderly subjects)
Number of subjects: 10
Study 7957521 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral colchicine (both groups)
Number of subjects: 10
Study 2824297 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical human fibroblast interferon (HuIFN‐beta) 7.5 x 10(5) IU/ml, one drop 5 times daily
Number of subjects: 50
Study 2824297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 30063152 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous Oxide (RA technique)
Number of subjects: 90
Study 28557747 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodide supplementation (sodium iodide, 30 μg/kg per day)
Number of subjects: 1273
Study 28557747 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sodium chloride, 30 μg/kg per day)
Number of subjects: 1273
Study 26034741 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback therapy
Number of subjects: 22
Study 26034741 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 22
Study 23824214 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose reduction/discontinuation (DR) strategy
Number of subjects: 128
Study 23824214 — intervention group
Group type: COMPARATOR
Intervention: Maintenance treatment (MT)
Number of subjects: 128
Study 20335543 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g soy protein and 100 mg isoflavones
Number of subjects: 180
Study 20335543 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g milk protein and 100 mg isoflavones
Number of subjects: 180
Study 20335543 — intervention group
Group type: COMPARATOR
Intervention: 15 g milk protein
Number of subjects: 180
Study 18068888 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving ambulance vehicle
Number of subjects: 11
Study 18068888 — intervention group
Group type: EXPERIMENTAL
Intervention: Flying helicopter
Number of subjects: 11
Study 18068888 — intervention group
Group type: COMPARATOR
Intervention: Staying at the scene (control)
Number of subjects: 11
Study 17075740 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop to teach prioritization of preventive services
Number of subjects: 0
Study 17075740 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 14693167 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with PAD
Number of subjects: 234
Study 14693167 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ischaemic rest pain
Number of subjects: 234
Study 14693167 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with ABPI < 0.52
Number of subjects: 234
Study 14693167 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 234
Study 11094589 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium administered after 15 min of sevoflurane exposure
Number of subjects: 40
Study 11094589 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium administered after 30 min of sevoflurane exposure
Number of subjects: 40
Study 11094589 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium administered after 60 min of sevoflurane exposure
Number of subjects: 40
Study 11094589 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium administered after 90 min of sevoflurane exposure
Number of subjects: 40
Study 8838440 — intervention group
Group type: COMPARATOR
Intervention: Meloxicam 5 mg
Number of subjects: 44
Study 8838440 — intervention group
Group type: COMPARATOR
Intervention: Meloxicam 10 mg
Number of subjects: 44
Study 8838440 — intervention group
Group type: COMPARATOR
Intervention: Meloxicam 20 mg
Number of subjects: 44
Study 8838440 — intervention group
Group type: COMPARATOR
Intervention: Meloxicam 30 mg
Number of subjects: 44
Study 8838440 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 15 mg (i.v.)
Number of subjects: 44
Study 8838440 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 15 mg (i.m.)
Number of subjects: 44
Study 1562335 — intervention group
Group type: EXPERIMENTAL
Intervention: Enlarging intravenous (IV) catheter
Number of subjects: 30
Study 1562335 — intervention group
Group type: COMPARATOR
Intervention: Standard Teflon IV catheters
Number of subjects: 30
Study 3907425 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen (1 mg b.i.d.)
Number of subjects: 11
Study 3907425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 30607809 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-3L
Number of subjects: 148
Study 30607809 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 148
Study 30607809 — intervention group
Group type: EXPERIMENTAL
Intervention: SF-6D
Number of subjects: 148
Study 30607809 — intervention group
Group type: EXPERIMENTAL
Intervention: HUI3
Number of subjects: 148
Study 29351736 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual introduction
Number of subjects: 181
Study 29351736 — intervention group
Group type: EXPERIMENTAL
Intervention: Camera focus on patient at emotional moments
Number of subjects: 181
Study 29351736 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-only variant with audiovisual introduction
Number of subjects: 181
Study 29351736 — intervention group
Group type: COMPARATOR
Intervention: Written introduction
Number of subjects: 181
Study 29351736 — intervention group
Group type: COMPARATOR
Intervention: Camera focus on physician only and neutral moments
Number of subjects: 181
Study 29351736 — intervention group
Group type: COMPARATOR
Intervention: Camera focus on physician and patient at neutral moments
Number of subjects: 181
Study 27513477 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychological intervention based on gratitude and mindfulness for 4 weeks
Number of subjects: 120
Study 27513477 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 120
Study 24126899 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed basket weave (CBW) ankle taping
Number of subjects: 12
Study 24126899 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 12
Study 22487150 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling exercise at 30% of maximal oxygen consumption (%VO(2max)) for 60 min
Number of subjects: 7
Study 22487150 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling exercise at 50% of maximal oxygen consumption (%VO(2max)) for 30 min
Number of subjects: 7
Study 20473046 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance Commitment Therapy self-help book with weekly telephone support
Number of subjects: 11
Study 20473046 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 11
Study 17986525 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 100 mg with Amlodipine 5 mg
Number of subjects: 0
Study 17986525 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 100 mg with Valsartan 320 mg
Number of subjects: 0
Study 17986525 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 100 mg with Ramipril 5 mg
Number of subjects: 0
Study 17986525 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin alone
Number of subjects: 0
Study 17986525 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin with Amlodipine, Valsartan, or Ramipril
Number of subjects: 0
Study 16208642 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Rheumatology CD
Number of subjects: 354
Study 16208642 — intervention group
Group type: COMPARATOR
Intervention: Non-CD group
Number of subjects: 354
Study 11811571 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (2 g) in solution
Number of subjects: 5
Study 11811571 — intervention group
Group type: COMPARATOR
Intervention: Creatine in meat
Number of subjects: 5
Study 11811571 — intervention group
Group type: COMPARATOR
Intervention: Creatine as a lozenge (solid form)
Number of subjects: 5
Study 11811571 — intervention group
Group type: COMPARATOR
Intervention: Creatine as a crystalline suspension in ice cold water
Number of subjects: 5
Study 11811571 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine in solution (as a control)
Number of subjects: 5
Study 10524687 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosorba column treatment
Number of subjects: 91
Study 10524687 — intervention group
Group type: COMPARATOR
Intervention: Sham apheresis
Number of subjects: 91
Study 8523876 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone before cardiopulmonary bypass
Number of subjects: 24
Study 8523876 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin protocol
Number of subjects: 24
Study 8523876 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study 1724023 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapulmonary and endobronchial administration of antibiotics and contrykal
Number of subjects: 89
Study 1724023 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous droplet contrykal
Number of subjects: 89
Study 1724023 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with antibacterial and antiproteolytic drugs
Number of subjects: 89
Study 7048914 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir
Number of subjects: 97
Study 7048914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 30797258 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate TotalSF containing 0.454% SnF2 and 1% zinc phosphate
Number of subjects: 0
Study 30797258 — intervention group
Group type: COMPARATOR
Intervention: Regular fluoride toothpaste
Number of subjects: 0
Study 29723896 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone 25 mg once daily (up-titrated to 50 mg/day after 4 weeks)
Number of subjects: 110
Study 29723896 — intervention group
Group type: COMPARATOR
Intervention: MR blocker treatment
Number of subjects: 110
Study 26878894 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized normalized feedback on gambling status by email
Number of subjects: 0
Study 26878894 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help book with a Cognitive Behavioral Therapy (CBT) program without guidance
Number of subjects: 0
Study 26878894 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT program emailed weekly by a trained psychologist with personalized guidance
Number of subjects: 0
Study 26878894 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 0
Study 24551191 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental perception of child's weight status
Number of subjects: 783
Study 24551191 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental misperception
Number of subjects: 783
Study 24551191 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental intention to improve child overweight-related health behavior
Number of subjects: 783
Study 24551191 — intervention group
Group type: EXPERIMENTAL
Intervention: Child meeting guidelines of health behaviors
Number of subjects: 783
Study 22762376 — intervention group
Group type: EXPERIMENTAL
Intervention: FitFor2 exercise program (aerobic and strengthening exercises, two sessions per week)
Number of subjects: 121
Study 22762376 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 121
Study 22762376 — intervention group
Group type: EXPERIMENTAL
Intervention: FitFor2 exercise program
Number of subjects: 121
Study 21072898 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI (lansoprazole 30 mg)
Number of subjects: 60
Study 21072898 — intervention group
Group type: COMPARATOR
Intervention: H2RA (famotidine 40 mg or ranitidine 300 mg)
Number of subjects: 60
Study 21072898 — intervention group
Group type: COMPARATOR
Intervention: Both groups (PPI and H2RA)
Number of subjects: 60
Study 17999221 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of anxiety
Number of subjects: 0
Study 17999221 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive anxiety
Number of subjects: 0
Study 17999221 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual difference variables
Number of subjects: 0
Study 15023168 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor treatment with surgery (group 1)
Number of subjects: 228
Study 15023168 — intervention group
Group type: COMPARATOR
Intervention: Proton pump inhibitor treatment without surgery (group 2)
Number of subjects: 228
Study 12116723 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered toothbrush
Number of subjects: 80
Study 12116723 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 80
Study 10439688 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (n = 80)
Number of subjects: 160
Study 10439688 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (n = 80)
Number of subjects: 160
Study 7843710 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 88
Study 7843710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 2240641 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% lidocaine with epinephrine
Number of subjects: 45
Study 2240641 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0% lidocaine with epinephrine
Number of subjects: 45
Study 2240641 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5% lidocaine with epinephrine
Number of subjects: 45
Study 2240641 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 45
Study 595585 — intervention group
Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (HCG) injections
Number of subjects: 0
Study 595585 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 0
Study 31329489 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 0
Study 31329489 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0